Pancreatic Ductal Carcinoma
8 clinical trials · Condition
◉ Watch Pancreatic Ductal Carcinoma
| Record | Firm | Date |
|---|---|---|
| A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors (NCT05293496) | MacroGenics | 2022-04-19 |
| Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation (NCT05288205) | Allist Pharmaceuticals, Inc. | 2022-04-14 |
| Recurrence After Whipple's (RAW) Study (NCT04596865) | University Hospital Plymouth NHS Trust | 2020-10-12 |
| A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China (NCT04121286) | Allist Pharmaceuticals, Inc. | 2020-07-14 |
| A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors (NCT04045496) | Jacobio Pharmaceuticals Co., Ltd. | 2019-09-26 |
| Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer (NCT02243007) | Massachusetts General Hospital | 2014-09-01 |
Track Pancreatic Ductal Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.